Unblinded ASCOT study results do not rule out that muscle symptoms are an adverse effect of statins
- PMID: 29056606
- DOI: 10.1136/ebmed-2017-110783
Unblinded ASCOT study results do not rule out that muscle symptoms are an adverse effect of statins
Keywords: coronary heart disease; internal medicine; lipid disorders; preventive medicine; primary care.
Conflict of interest statement
Competing interests: TJ has received research and consulting fees from Amgen and Regeneron/Sanofi.
Comment on
-
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.Lancet. 2017 Jun 24;389(10088):2473-2481. doi: 10.1016/S0140-6736(17)31075-9. Epub 2017 May 2. Lancet. 2017. PMID: 28476288 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical